Zhongyi Anke Biotech is a company that provides Health care, Tetravalent Meningococcal Vaccine, Rubella vaccine and more. Zhongyi Anke Biotech is headquartered in China Guangdong. Zhongyi Anke Biotech was founded in 2001. Zhongyi Anke Biotech has a total of 45 patents
A quick overview of tech portfolio with the top keywords and phrases extracted from patents of Zhongyi Anke Biotech
Download
High Related Markets
Mentioned companies in the market reports of major market categories and sectors by Zhongyi Anke Biotech
Sign up to view the full data
Free Trial Now
Download
Innovation Matrix
visualizing technology portfolio of hot application areas and blank areas for Zhongyi Anke Biotech
Time Range:
Overall
Overall
1 year
3 year
5 year
Application Domain L2
Application Domain L2
Application Domain L3
Application Domain L4
High-Tech Industry L1
High-Tech Industry L2
Tech Topic L2
Tech Topic L3
Timeline
Tech Topic L2
Tech Topic L2
Tech Topic L3
High-Tech Industry L1
High-Tech Industry L2
Application Domain L2
Application Domain L3
Application Domain L4
Download
Subsidiary Lists
Subsidiaries with patent applications for Zhongyi Anke Biotech
Sign up to view the full data
Free Trial Now
Download
Zhongyi Anke Biotech Frequently Asked Questions
What is Zhongyi Anke Biotech's industry?
Zhongyi Anke Biotech is in the industry of:Pharmaceutical and Medicine ManufacturingResearch and Development in the Physical, Engineering, and Life SciencesDrugs and Druggists' Sundries Merchant Wholesalers
What technical fields has Zhongyi Anke Biotech researched?
Zhongyianke has launched a flu vaccine and is conducting clinical trials on four other human vaccines: a tetravalent influenza vaccine, a tetravalent meningococcal...